Search





Search





Markets
/
Stocks
/
nasdaq-plyx
/

Polaryx Therapeutics Ord Shs

PLYX

Add to Watchlist

2.670USD

-0.740-21.70%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

126.41MMarket Cap

LossP/E TTM



Polaryx Therapeutics Ord Shs

2.670

-0.740-21.70%

Overview Financials Discussions Analysis Company

Overview

Financials

Discussions

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Polaryx Therapeutics Ord Shs to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---2.06M

Net income from continuing operations

---2.54M

Change in working capital

--14.00K

-Change in prepaid expenses

---395.00K

Cash from non-recurring investing activities

Cash from operating activities

---2.06M

Investing cash flow

Cash from non-current investing activities

Financing cash flow

Net cash from non-recurrent financing activities

Net cash flow

Beginning cash balance

--5.14M

Current period cash flow changes

---2.06M

Ending cash balance

--3.08M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

